This list is based on the watchlists of people on Stock Events who follow BB.MI. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Show more...
FAQ
What is BB Biotech stock price today?▼
The current price of BB.MI is €52.7 EUR — it has decreased by -19.17% in the past 24 hours. Watch BB Biotech stock price performance more closely on the chart.
What is BB Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BB Biotech stocks are traded under the ticker BB.MI.
Is BB Biotech stock price growing?▼
BB.MI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year BB Biotech has showed a +0% increase.
What were BB Biotech earnings last quarter?▼
BB.MI earnings for the last quarter are -6.64 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does BB Biotech pay dividends?▼
Yes, BB.MI dividends are paid annual. The last dividend per share was 2.88 EUR. As of today, Dividend Yield (FWD)% is 3.57%.
How many employees does BB Biotech have?▼
As of April 05, 2026, the company has 10 employees.
In which sector is BB Biotech located?▼
BB Biotech operates in the Healthcare sector.
When did BB Biotech complete a stock split?▼
BB Biotech has not had any recent stock splits.
Where is BB Biotech headquartered?▼
BB Biotech is headquartered in Kusnacht, CH.